Development of a novel diffusion-based method to estimate the size of the aggregated Aβ species responsible for neurotoxicity

Biotechnology and Bioengineering

Volumn 80, Issue 1, 2002, Pages 50-59

  Wang, Steven S S ^a   Becerra Arteaga, Alejandro ^a   Good, Theresa A ^a  

^a Texas AandM University   (United States)

Author keywords

Alzheimer's disease; A ; Diffusion; Diffusion coefficient; Molecular weight; Neurotoxicity

Indexed keywords

DISEASES; NEUROLOGY; OLIGOMERS; PROTEINS; SENSITIVITY ANALYSIS; TOXICITY;

NEURODEGRADATION;

BIOTECHNOLOGY;

AMYLOID BETA PROTEIN; OLIGOMER;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; HUMAN; HUMAN CELL; HYDRODYNAMICS; MOLECULAR WEIGHT; NERVE DEGENERATION; NEUROFILAMENT; NEUROTOXICITY; PROTEIN AGGREGATION; PROTEIN STRUCTURE; SENILE PLAQUE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CELL SURVIVAL; DIFFUSION; EQUIPMENT DESIGN; FLOW CYTOMETRY; HUMANS; MACROMOLECULAR SUBSTANCES; MODELS, BIOLOGICAL; MOLECULAR WEIGHT; NEUROBLASTOMA; PROTEIN INTERACTION MAPPING; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEPHAROSE; SPECIES SPECIFICITY; TOXICITY TESTS; TUMOR CELLS, CULTURED;

EID: 0037026929     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/bit.10347     Document Type: Article

References (38)

1. Busciglio J, Yeh J, Yankner BA. 1993. Beta-Amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins. J Neurochem 61:1565-1568.
2. Dutton G. 1994. Neuroscience firms explore latest advances in amyloid protein research. Genetic Engineering News 14:7-8
3. Esler WP, Stimson ER, Jennings JM, Vinters HV, Ghilardi JR, Lee JP, Mantyh PW, Maggio JE. 2000. Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry 39:6288-6295.
4. Geankopolis C. 1978. Transport processes and unit operations. Boston: Allyn and Bacon.
5. Good TA. 1996. The aggregation state specific role of beta-amyloid peptide in neurotoxicity associated with Alzheimer's disease. Ph.D. dissertation, University of Wisconsin, Madison.
6. Good TA, Smith DO, Murphy RM. 1996. Beta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons. Biophys J 70:296-304.
7. Gorevic PD, Castano EM, Sarma R, Frangione B. 1987. Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic x-ray diffraction pattern. Biochem Biophys Res Commun 147:854-862.
8. Hartley DM, Walsh DM, Ye CP, Diehl T, Vasquez S, Vassilev PM, Teplow DB, Selkoe DJ. 1999. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19:8876-8884
9. Howlett DR, Jennings KH, Lee DC, Clark MS, Brown F, Wetzel R, Wood SJ, Camilleri P, Roberts GW. 1995. Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration 4:23-32.
10. Johnson EM, Berk DA, Jain RK, Deen WM. 1995. Diffusion and partitioning of proteins in charged agarose gels. Biophys J 68:1561-1568.
11. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B. 1987. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733-736.
12. Kelly JW. 1996. Alternative conformations of amyloidogenic proteins govern their behavior. Curr Opin Struct Biol 6:11-17.
13. Kelly JW. 1998. The alternative conformations of amyloidogenic proteins and their multi- step assembly pathways. Curr Opin Struct Biol 8:101-106.
14. Koh JY, Yang LL, Cotman CW. 1990. Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res 533:315-320.
15. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL. 1998. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448-6453.
16. Lansbury PT, Jr. 1999. Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease. Proc Natl Acad Sci USA 96:3342-3344.
17. Laurent TC. 1967. Determination of the structure of agarose gels by gel chromatography. Biochim Biophys Acta 136:199-205.
18. Lee Y, Yin J. 1996. Imaging the propagation of viruses. Biotechnol Bioeng 52:438-442.
19. Murphy RM, Pallitto MM. 2000. Probing the kinetics of beta-amyloid self-association. J Struct Biol 130:109-122.
20. Ogston AG, Preston BN, Wells JD, Snowden JM. 1973. Transport of compact particles through solutions of chain- polymers. Proc Royal Soc London Series a-Math Phys Eng Sci 333:297-316.
21. Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW. 1991a. Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. Eur J Pharmacol 207:367-368.
22. Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW. 1991b. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 563:311-314.
23. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW. 1993. Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state. J Neurosci 13:1676-1687.
24. Pluen A, Netti PA, Jain RK, Berk DA. 1999. Diffusion of macromolecules in agarose gels: Comparison of linear and globular configurations. Biophys J 77:542-552.
25. Pollack SJ, Sadler, II, Hawtin SR, Tailor VJ, Shearman MS. 1995. Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells. Neurosci Lett 184:113-116.
26. Seilheimer B, Bohrmann B, Bondolfi L, Muller F, Stuber D, Dobeli H. 1997. The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology. J Struct Biol 119:59-71.
27. Selkoe DJ. 1994. Alzheimer's disease: A central role for amyloid [see comments]. J Neuropathol Exp Neurol 53:438-447.
28. Shen CL, Fitzgerald MC, Murphy RM. 1994. Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide. Biophys J 67:1238-1246.
29. Shen CL, Murphy RM. 1995. Solvent effects on self-assembly of betaamyloid peptide. Biophys J 69:640-651.
30. Sipe JD. 1992. Amyloidosis. Annu Rev Biochem 61:947-975.
31. Sipe JD. 1994. Amyloidosis. Crit Rev Clin Lab Sci 31:325-354
32. Stewart WE, Sorensen JP. 1981. Bayesian-estimation of common parameters from multi-response data with missing observations. Technometrics 23:131-141.
33. Stewart WE. 1987. Multiresponse parameter-estimation with a new and noninformative prior. Biometrika 74:557-562.
34. Urbanc B, Cruz L, Buldyrev SV, Havlin S, Irizarry MC, Stanley HE, Hyman BT. 1999. Dynamics of plaque formation in Alzheimer's disease. Biophys J 76:1330-1334.
35. Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A, Benedek GB, Selkoe DJ, Teplow DB. 1999. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem 274:25945-25952.
36. Wang SS-S, Rymer D, Good TA. 2001. Reduction in cholesterol and sialic acid content protects cells from the toxic effects of betaamyloid peptides. J Biol Chem 276:42027-42034.
37. Ward RV, Jennings KH, Jepras R, Neville W, Owen DE, Hawkins J, Christie G, Davis JB, George A, Karran EH, Howlett DR. 2000. Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide. Biochem J 348 Pt 1:137-144.
38. Whitson JS, Mims MP, Strittmatter WJ, Yamaki T, Morrisett JD, Appel SH. 1994. Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E. Biochem Biophys Res Commun 199:163-170.